Option C: MOTS-c-Led Stack with Low-Dose Retatrutide Best for: Research contexts where GI tolerability is a primary concern, or where the focus is more on metabolic health and aging markers than aggressive fat loss
In December 2024, the FDA abruptly determined that the tirzepatide shortage had resolved and removed these products from its shortage list, effectively terminating compounders' legal authority to produce these drugs
Annual plans offer tiered access to biomarker testing and virtual clinical follow up, designed to deepen engagement and enable cross selling of additional treatments
Growth hormone is central to how you repair, recover, and maintain a lean, strong body and it declines steadily with age, which is why recovery slows and body composition drifts over time
Electrolyte imbalances, particularly hyponatremia or hypokalemia, may accompany dehydration and further contribute to weakness and tiredness